Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FPNVK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,197
Award facts
- Contract value 100% obligated
- $20,197.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,197.05 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
RINVOQ ER (upadacitinib extended-release) is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions, making this delivery order consistent with AmerisourceBergen's established role as a critical pharmaceutical vendor for military and federal healthcare systems. The award demonstrates the contractor's capability to fulfill federal medical procurement requirements through competitive procurement processes and reflects DLA's continued reliance on AmerisourceBergen as a primary source for specialty pharmaceutical products supporting Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FPNVK?
SPE2DB25FPNVK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FPNVK worth?
The government has obligated $20,197 on SPE2DB25FPNVK.
Is contract SPE2DB25FPNVK an order under another contract?
Yes. SPE2DB25FPNVK is a delivery order under SPE2DB20D2001, an indefinite delivery contract.
Was contract SPE2DB25FPNVK competed?
The extent of competition for SPE2DB25FPNVK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award